Search Documents and Resources

documents

Benchmarking Dissent Processes and Best Practices

letters

POGO Opposes Califf Nomination Due to Conflicts of Interest POGO Urges Senate to Vote Against Nominee to the FDA POGO Asks President to Withdraw FDA Nominee POGO Letter to Associate Commissioner Warner, FDA, Questioning FDA's Handling of Conflicts of Interest on FDA Advisory Committees POGO and Partners Oppose House Bill that Allows FDA More Secrecy POGO and Groups Support Better Information on Clinical Trials POGO and Partners Oppose FDA Secrecy POGO Letter: FDA Advisors on Yaz and Yasmin Have Industry Ties POGO Letter Urges FDA Not to Weaken Conflict of Interest Standards at Center for Drug Evaluation and Research POGO Letter to FDA Commissioner Hamburg Concerning the Potentially Dangerous Interaction of the Drugs Seroquel and Methodone POGO Asks DHHS Secretary Sebelius to Reinvestigate FDA's Negligent Oversight of Unsafe Medical Devices POGO Letter to FDA Commissioner Margaret Hamburg Regarding Potentially Dangerous Drug Interaction Invovling Seroquel and Methadone POGO's letter to Deputy HHS IG on FDA's CDRH's low standard of medical devices approval The Finances Of FDA Advisory Committee Members: If Information Must Be Withheld, Let It Be Done Openly POGO's letter to Commissioner Hamburg regarding medical devices POGO Letter to FDA's Daniel Schultz MD regarding a policy decision by CDRH to discontinue inspections of nonclinical laboratories POGO Asks FDA Head to Have Deadly Syringe Incident Investigated POGO letter to FDA's Daniel Schultz MD regarding the lack of GLP inspections POGO Follow-up letter to CDRH Director Daniel Schultz POGO Letter to CDRH Director Daniel Schultz regarding a series of questions about the apparent decision not to enforce the GLP regulation
    • Mission and Vision
    • Board & Staff
    • Financials
    • Contact Us
    • Privacy Policy
    • Donor Privacy Policy
    • Explore our work
    • Center for Defense Information
    • The Constitution Project
    • Congressional Oversight Initiative
    • Policy Letters
    • Reports
    • Testimony
    • For Oversight Staff
    • Whistleblower Resources
    • Report Corruption
  • Take Action
  • Sign Up
  • Donate
  • facebook
  • twitter
  • instagram
  • youtube
    • Mission and Vision
    • Board & Staff
    • Financials
    • Contact Us
    • Privacy Policy
    • Donor Privacy Policy
    • Explore our work
    • Center for Defense Information
    • The Constitution Project
    • Congressional Oversight Initiative
    • Policy Letters
    • Reports
    • Testimony
    • For Oversight Staff
    • Whistleblower Resources
    • Report Corruption
Project On Government Oversight
  • Take Action
  • Sign Up
  • Donate
  • Afghanistan
  • More Topics
  • About
  • Mission & History
  • Board & Staff
  • Financials
  • Take Action
  • For Federal Employees
  • COVID-19: Tips
  • Contact Us
  • Privacy Policy
  • Subscribe
  • Donate
Project On Government Oversight
    • Mission and Vision
    • Board & Staff
    • Financials
    • Contact Us
    • Privacy Policy
    • Donor Privacy Policy
    • Explore our work
    • Center for Defense Information
    • The Constitution Project
    • Congressional Oversight Initiative
    • Policy Letters
    • Reports
    • Testimony
    • For Oversight Staff
    • Whistleblower Resources
    • Report Corruption
  • Take Action
  • Sign Up
  • Donate

Food and Drug Administration (FDA)

Food and Drug Administration (FDA)

Latest

Avoiding the Subject: On Pfizer Vaccine Quality Control, FDA Says Less than European Counterpart

investigation | March 19, 2021

Read

Latest

Hearing Without Listening

analysis | December 16, 2020

Read
  • FDA Panel Reviewing Pfizer Vaccine Leaves Out Some Experts Who Raised Concerns

    investigation | December 9, 2020

  • FDA Whitewashes Warnings About Coronavirus Vaccine Trials

    analysis | November 2, 2020

  • HHS, Inc.: Big Pharma Ties Draw Pandemic Response Concerns

    investigation | October 26, 2020

  • Some FDA Advisors Tapped to Review Coronavirus Vaccines Received Payments from Vaccine Companies

    investigation | October 21, 2020

  • Corrupted: Will Cronyism and Politics Hamper the Vaccine Program?

    analysis | August 13, 2020

  • Stifling Dissent

    report | July 31, 2020

  • Coronavirus Relief Act Gives Drug Makers New Sway Over FDA

    investigation | May 5, 2020

  • Following the (Drug) Money

    investigation | May 5, 2020

Previous 1 2 3 4 5 Next

Site Footer

  • facebook
  • twitter
  • instagram
  • youtube
  • Press Center
  • Contact Us
  • Careers
  • Briefing
  • Newsletters
  • Publications
  • Report Corruption
Better Business Bureau Accredited Charity CharityWatch Top Rated Charity Great Nonprofits 2021 Top-Rated Charity Navigator Four-Star Charity

©2023 POGO | Privacy Policy

Project On Government Oversight logo

Project On Government Oversight

Oversight in your inbox.